Press Release
Hootan Troy Farahmand and Alexso, Inc. Set New Standards for Purpose-Driven Corporate Philanthropy
Los Angeles, California, 2nd January 2026, ZEX PR WIRE, At a time when public trust in corporations is increasingly tied to social responsibility, Hootan Troy Farahmand is redefining what meaningful corporate philanthropy looks like in modern healthcare. As Chief Executive Officer of Alexso, Inc., a nationwide pharmaceutical distributor, Farahmand has positioned the company as more than a supplier of medical products. Under his leadership, Alexso has become a platform for service, access, and long-term community impact.
Rather than treating philanthropy as a side initiative, Farahmand integrates giving into the company’s operational and cultural framework. His approach reflects a belief that healthcare businesses have a responsibility to actively support the communities they serve. Through targeted donations, strategic partnerships, and employee engagement, Alexso continues to raise expectations for how corporations can contribute to public well-being.
A Mission That Extends Beyond Distribution
Alexso, Inc. operates across all 50 states, supplying pharmaceuticals, medical devices, and nutraceuticals to hospitals, clinics, rehabilitation centers, and physician practices nationwide. While the company’s operational growth has been substantial, Farahmand ensures that its mission remains focused on improving patient outcomes.
He views access to healthcare resources as a shared responsibility. Every expansion into a new market represents an opportunity to reach underserved providers and patients. This philosophy guides Alexso’s distribution strategy and informs its philanthropic decisions. The company prioritizes partnerships that directly benefit patient care, especially in communities where access to quality healthcare remains limited.
By aligning business growth with social impact, Farahmand has established a model in which corporate success supports broader public good.
Strategic Giving With Measurable Impact
Farahmand believes that effective philanthropy must be intentional and results driven. Under his direction, Alexso has supported children’s hospitals, nonprofit clinics, rehabilitation centers, and mental health organizations through donations of medical products and essential supplies. These contributions focus on meeting real clinical needs rather than symbolic gestures.
Working closely with healthcare professionals, including Dr. Farbod Melamed, Pharm.D., Alexso identifies organizations that lack resources but deliver critical services. Together, they help ensure that donated products reach facilities where they can make an immediate difference in patient care.
This collaborative approach allows Alexso to align donations with medical priorities while maintaining compliance and safety standards. As a result, the company’s philanthropic efforts support both patient outcomes and operational accountability.
Advancing Safer Healthcare Solutions
A key focus of Alexso’s philanthropic mission involves expanding access to safer treatment options. Farahmand has been a strong advocate for non-opioid pain management solutions and advanced nutraceuticals. He recognizes the role distributors play in shaping prescribing practices by ensuring that clinicians have reliable alternatives to opioid-based medications.
Through donations and expanded product offerings, Alexso supports healthcare providers seeking to reduce dependency risks while maintaining effective pain management. Farahmand’s leadership in this area reflects a broader commitment to public health and patient safety.
By prioritizing responsible distribution, Alexso reinforces its role as a partner in addressing some of the most pressing challenges facing the healthcare system today.
Leadership Informed by Legal and Business Expertise
Farahmand’s ability to lead purpose-driven philanthropy is rooted in his diverse professional background. As a licensed attorney with experience in intellectual property and corporate law, he understands the regulatory and ethical considerations that govern pharmaceutical distribution. This knowledge ensures that Alexso’s charitable initiatives comply with all legal requirements while maintaining transparency.
In addition to his legal career, Farahmand has managed real estate investments and operated retail businesses. These experiences sharpened his skills in strategic planning, operational efficiency, and customer-focused design. He brings this same discipline to Alexso’s philanthropic programs, ensuring they remain sustainable and scalable.
His leadership demonstrates that strong governance and compassion can coexist, strengthening both business performance and community trust.
Cultivating a Culture of Responsibility
Philanthropy at Alexso is not limited to executive decision making. Farahmand encourages employees at all levels to participate in community initiatives and charitable efforts. The company organizes donation drives, volunteer opportunities, and outreach programs that allow team members to contribute directly to causes aligned with Alexso’s mission.
This inclusive approach fosters a sense of shared purpose across the organization. Employees understand that their work supports both healthcare providers and the communities those providers serve. Farahmand believes that when people feel connected to a larger mission, they bring greater care and accountability to their roles.
By embedding philanthropy into workplace culture, Alexso reinforces its commitment to ethical leadership and long-term impact.
Supporting the Next Generation
Beyond immediate healthcare needs, Farahmand is committed to investing in the future. Alexso supports educational initiatives that introduce students to careers in science, technology, pharmacy, and entrepreneurship. These programs aim to inspire young people while addressing workforce shortages in healthcare and related fields.
Farahmand views education as a powerful form of philanthropy. By supporting mentorship and learning opportunities, Alexso helps cultivate future professionals who value service and responsibility. This forward-looking approach ensures that the company’s impact extends well beyond current operations.
Setting a Higher Standard for Corporate Citizenship
As conversations around corporate responsibility continue to evolve, Farahmand’s leadership offers a clear example of what purpose-driven philanthropy can achieve. He demonstrates that healthcare companies can grow while remaining deeply connected to the needs of patients and communities.
Alexso’s philanthropic initiatives are not isolated acts of charity. They reflect a long-term strategy grounded in access, safety, and collaboration. By aligning corporate resources with social priorities, Farahmand sets a higher standard for corporate citizenship within the healthcare sector.
Looking Forward With Purpose
Farahmand continues to guide Alexso with a focus on expanding access, improving efficiency, and strengthening community partnerships. Future initiatives include deeper support for mental health services, expanded donations to pediatric care programs, and continued investment in non-opioid treatment solutions.
Through steady leadership and a clear commitment to service, Hootan Troy Farahmand proves that philanthropy is most powerful when it is purposeful, consistent, and integrated into every aspect of business. His work with Alexso stands as a model for how healthcare companies can lead with integrity while making a lasting difference.
About Author
Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.
New York City, NY, USA, July 22nd, 2026, FinanceWire
Knot, the leading merchant connectivity platform, has announced its partnership with RBC, Canada’s largest bank, to make RBC cards the default payment method for millions of cardholders wherever they spend. Using Knot’s CardSwitcher, RBC cardholders can set their RBC card as the saved payment method at their favorite merchants directly from the RBC mobile app, without manually entering card details. The partnership marks Knot’s first expansion beyond the United States.
Keeping RBC Top of Wallet
One of the hardest moments in payments is the first one. When a cardholder gets a new RBC card, putting it to use means hunting down every merchant where a card is already saved and updating each one by hand, so a new card often sits idle for weeks before it sees real spend. The partnership removes that friction. From the RBC app, cardholders add their RBC card to their preferred merchants in a few taps and set it as the saved payment method at the places they already spend, from the day the card is in hand.
For RBC, that means a card that goes to work immediately instead of waiting to be activated across a cardholder’s everyday spend. Placing the card as the default at the merchants cardholders use most keeps it top of wallet, turning a new RBC card from an occasional choice into a go-to payment method from the start and driving repeat spend and deeper loyalty to RBC.
Expanding into Canada with the Country’s Largest Bank
For years, Knot has built the merchant connectivity layer across the United States, linking the people, financial institutions, and merchants behind everyday spend. RBC is where that infrastructure goes international for the first time. Canada is Knot’s first market beyond the U.S., and launching it with the country’s largest bank sets the standard for every market that follows.
RBC did not become Canada’s largest bank by standing still. They move early, they invest in their clients, and they push the industry forward. That is exactly the kind of partner Knot wants to build alongside, and the reason RBC is the right first step into a new market. Bringing CardSwitcher to Canadian cardholders is the start of a longer roadmap, both for what Knot and RBC build together and for where Knot goes next.
About RBC
Royal Bank of Canada is a global financial institution with a purpose-driven, principles-led approach to delivering leading performance. Its success comes from the 101,000+ employees who leverage their imaginations and insights to bring the company’s vision, values, and strategy to life so it can help its clients thrive and communities prosper. As Canada’s biggest bank, and one of the largest in the world based on market capitalization, RBC has a diversified business model with a focus on innovation and providing exceptional experiences to its more than 19 million clients in Canada, the U.S., and 27 other countries. Learn more at rbc.com.
About Knot
Knot is the leading merchant connectivity platform, simplifying how consumers, merchants, and financial institutions interact. CardSwitcher is the foundation of Knot’s product suite, letting users update and manage card-on-file payments across hundreds of merchants. Building on the same connectivity infrastructure, TransactionLink delivers SKU-level transaction data, and SubManager gives users a single place to view and manage their subscriptions. By removing friction at every step, Knot helps financial institutions grow engagement, loyalty, and spend.
Users can learn more at KnotAPI.com and connect with Knot on X (@KnotAPIs) and LinkedIn (LinkedIn.com/company/KnotAPI).
Contact
Head of Growth
Jose Del Real
Knot
press@knotapi.com
About Author
Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.
New York City, USA, July 22nd, 2026, FinanceWire
RedotPay, a global stablecoin-based payment fintech, today announced it has been named to CNBC’s World’s Top Fintech Companies 2026 list, in the Payments category. RedotPay’s inclusion in the prestigious list reflects the growth of the company, which is the global leader in stablecoin consumer payments by volume and has over eight million users.
The list is compiled independently by CNBC and Statista, based on the past year’s performance data. Now in its fourth edition, the list honors 500 companies across nine market segments — Payments, Wealth Technology, Neobanking, Alternative Financing, Digital Assets, Enterprise Fintech, Insurtech, Regtech, and Others. For each segment, performance indicators and other metrics were used to evaluate and select companies for inclusion on the list.
“We’re honored to be recognized as a leading payments fintech company by CNBC and Statista. Stablecoin-powered payments are quickly becoming trusted by millions around the world, especially among those who don’t have reliable access to traditional banking infrastructure. We remain focused on making everyday stablecoin payments accessible to many more around the world,” said Michael Gao, CEO and Co-Founder of RedotPay.
The recognition reflects RedotPay’s continued focus on making stablecoin payments accessible, reliable, and compliant for customers and businesses globally. The company recently surpassed $1bn in monthly total payment volume. Its investors include Goodwater, Galaxy, Pantera, and Lightspeed.
About RedotPay
RedotPay is a global stablecoin-based payment fintech that integrates blockchain solutions with traditional banking and finance infrastructure. Our intuitive platform empowers millions around the world to spend and send digital assets, ensuring faster, more accessible and inclusive financial services. RedotPay advances financial inclusion for the unbanked and supports crypto enthusiasts, driving global adoption of secure and flexible stablecoin-powered financial solutions to bring crypto to real life. For more information, visit www.redotpay.com.
Contact
RedotPay
press@redotpay.com
About Author
Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.
Press Release
ISO-Accredited Lab Testing Exposes 86% Failure Rate in Amazon Creatine Gummies, with Over Half Containing Near-Zero Active Ingredients
Dyad Labs Certificates of Analysis (#1406738-1 through #1462360-1) confirm widespread misbranding and dosage fraud across 15 popular e-commerce listings.
SALT LAKE CITY, Utah / LOS ANGELES, Calif. — A comprehensive market investigation evaluating 15 top-selling creatine gummy products on Amazon has uncovered systemic label fraud and active-ingredient under-dosing in the sports nutrition sector.
Analytical testing performed by Dyad Labs (A Mérieux NutriSciences Company, accredited under ISO/IEC 17025:2017) reveals that 13 out of 15 tested brands (86.7%) failed to meet their labeled claims of 5,000 mg of Creatine Monohydrate per serving.
The quantitative analysis was conducted using Method GL-604 (Determination of Creatine Monohydrate by Ultra-Performance Liquid Chromatography – UPLC), the recognized testing standard for active supplement compounds.
Shocking Laboratory Findings Across 15 Tested ASINs
According to official Certificates of Analysis (COA), 60% of tested products (9 out of 15) contained less than 1,000 mg per serving, with several extreme cases delivering less than 0.5% of the active ingredient promised on their labels:
· Near-Zero Active Creatine (<25 mg/serving):
·
Asumtal ASIN:B0F5VRJHPT/COACert#1450795-1: Tested <23.6 mg/serving (Label claim: 5,000 mg).
WELLNESS LABSRX ASIN:B0DCC4R4Q5/COACert#1450796-1: Tested <23.9 mg/serving (Label claim: 5,000 mg).
eterlower ASIN:B0FWXGC15Y/COACert#1450798-1: Tested <24.0 mg/serving (Label claim: 5,000 mg).
TASTY GAINS Collagen ASIN:B0FYPWMPZ9/COACert#1450797-1: Tested <24.0 mg/serving (Label claim: 5,000 mg).
· Severe Mislabeling & Under-Dosing (<654 mg/serving):
·
ZyterX ASIN:B0FF1R5T1Q/COACert#1406740-1: Tested <420 mg/serving.
TASTY GAINS ASIN:B0FH5J5GS4/COACert#1406739-1: Tested <454 mg/serving.
OUTELANDE ASIN:B0F4QJP5L3/COACert#1462359-1: Tested <500 mg/serving.
INNER BRIGHTNESS ASIN:B0FNBN38V4/COACert#1462360-1: Tested <500 mg/serving.
Cytona ASIN:B0F8BKD1CQ/COACert#1406747-1: Tested <654 mg/serving.
· Substantial Shortfalls (26% to 52% Deficit):
·
TASTY GAINS ASIN:B0D7N3D5X9/COACert#1406741-1: Tested 2,390 mg/serving (52% under-dosed).
Natures Aid ASIN:B0F3JBGGGZ/COACert#1406738-1: Tested 3,330 mg/serving (33% under-dosed).
Arrae ASIN:B0DX1RRWSY/COACert#1450801-1: Tested 3,410 mg/serving (32% under-dosed).
OMNI Creatine ASIN:B0F7J6DQ1V/COACert#1460718-1: Tested 3,710 mg/serving (26% under-dosed).
· Near-Compliant Top Performers:
·
Nutravita ASIN:B0CXMV6FBG/COACert#1406746-1: Tested 4,570 mg/serving.
DANEW Pro ASIN:B0DJ5HXHZS/COACert#1460717-1: Tested 4,780 mg/serving.
Master Table: Dyad Labs Analytical Certificates (ISO 17025)
| Brand Name | ASIN | Certificate ID | Testing Method | Labeled Claim | UPLC Result | Compliance Status |
|---|---|---|---|---|---|---|
| Asumtal | B0F5VRJHPT | #1450795-1 | GL-604 (UPLC) | 5,000 mg | <23.6 mg | Severe Fraud (<0.5%) |
| WELLNESS LABSRX | B0DCC4R4Q5 | #1450796-1 | GL-604 (UPLC) | 5,000 mg | <23.9 mg | Severe Fraud (<0.5%) |
| TASTY GAINS | B0FYPWMPZ9 | #1450797-1 | GL-604 (UPLC) | 5,000 mg | <24.0 mg | Severe Fraud (<0.5%) |
| eterlower | B0FWXGC15Y | #1450798-1 | GL-604 (UPLC) | 5,000 mg | <24.0 mg | Severe Fraud (<0.5%) |
| ZyterX | B0FF1R5T1Q | #1406740-1 | GL-604 (UPLC) | 9,000 mg (Tot) | <420 mg | Severely Misbranded |
| TASTY GAINS | B0FH5J5GS4 | #1406739-1 | GL-604 (UPLC) | 5,000 mg | <454 mg | Severely Misbranded |
| OUTELANDE | B0F4QJP5L3 | #1462359-1 | GL-604 (UPLC) | 5,000 mg | <500 mg | Severely Misbranded |
| INNER BRIGHTNESS | B0FNBN38V4 | #1462360-1 | GL-604 (UPLC) | 5,000 mg | <500 mg | Severely Misbranded |
| Cytona | B0F8BKD1CQ | #1406747-1 | GL-604 (UPLC) | 5,000 mg | <654 mg | Severely Misbranded |
| TASTY GAINS | B0D7N3D5X9 | #1406741-1 | GL-604 (UPLC) | 5,000 mg | 2,390 mg | Substantial Deficit (-52%) |
| Natures Aid | B0F3JBGGGZ | #1406738-1 | GL-604 (UPLC) | 5,000 mg | 3,330 mg | Deficit (-33%) |
| Arrae | B0DX1RRWSY | #1450801-1 | GL-604 (UPLC) | 5,000 mg | 3,410 mg | Deficit (-32%) |
| OMNI Creatine | B0F7J6DQ1V | #1460718-1 | GL-604 (UPLC) | 5,000 mg | 3,710 mg | Deficit (-26%) |
| Nutravita | B0CXMV6FBG | #1406746-1 | GL-604 (UPLC) | 5,000 mg | 4,570 mg | Near-Compliant |
| DANEW Pro | B0DJ5HXHZS | #1460717-1 | GL-604 (UPLC) | 5,000 mg | 4,780 mg | Near-Compliant |
Formulation Bottlenecks in Gummy Manufacturing
Food science specialists explain that Creatine Monohydrate degrades rapidly into inactive creatinine when exposed to high processing temperatures, water activity, and acidic environments—conditions intrinsic to gummy candy manufacturing. Without advanced stabilization microencapsulation, the active compound either breaks down during production or is deliberately under-dosed by manufacturers to prevent texture degradation.
Regulatory Filings and Enforcement Escalation
The complete documentation package, referencing all 15 Dyad Labs Certificates of Analysis (#1406738-1 through #1462360-1), has been submitted to:
The U.S. Food and Drug Administration (FDA) MedWatch Safety Portal
The Federal Trade Commission (FTC) Bureau of Consumer Protection
State Attorneys General Offices for investigation into deceptive marketing practices
Consumer advocacy groups are demanding that e-commerce marketplaces enforce mandatory, third-party batch verification for all gummy-form supplement listings.
Note to Editors / Media Verification:
Complete, unedited Certificates of Analysis (COA Certificate IDs #1406738-1 through #1462360-1) issued by ISO/IEC 17025 accredited Dyad Labs are officially on file and available to accredited media representatives upon request
About Author
Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.
Knot Expands into Canada, Partnering with RBC, the Country’s Largest Bank
RedotPay Recognized as One of the World’s Top Fintech Companies by CNBC
ISO-Accredited Lab Testing Exposes 86% Failure Rate in Amazon Creatine Gummies, with Over Half Containing Near-Zero Active Ingredients
Benzinga Money Article Discusses How to Become Part of the 12% of Retirees Who Have Achieved the Recommended $550,000 Minimum Retirement Savings Threshold
Apu Apustaja Conquers New York with Lively Street Ads, Including Times Square Billboard
Bay Smokes Maintains Quality Amid Legislative Changes in the Hemp Industry
-
Press Release2 days ago
Samruk-Kazyna and Huawei Discuss AI Infrastructure Development in Kazakhstan
-
Press Release2 days ago
Kazakhstan and China to Establish a Smart Transportation Corridor
-
Press Release4 days ago
How ProfitPilot AI Is Transforming Intelligent Investing The Vision of Global Capital Partners Investments LLC
-
Press Release4 days ago
Brian Baldari, Brick NJ ResilExec Coach, Explains Why Adaptability Is the Leadership Skill That Separates Leaders Who Advance From Leaders Who Plateau
-
Press Release4 days ago
8 Cylinders Auto Repair Philadelphia Expands Professional Auto Repair and Maintenance Services
-
Press Release4 days ago
Where GCC’s Most Consequential Business Decisions Get Made
-
Press Release4 days ago
Joe Shields Brings Software Design Thinking to Hospitality Through States of Leisure’s Experience-First Approach
-
Press Release4 days ago
Terrance Bradford Tampa, FL Explains Why Problem-Solving Is One of Construction’s Most Valuable Skills